Bullty

Doctors Question Military's Testosterone Screening Plan

· news

A Dubious Prescription for Military Masculinity

Defense Secretary Pete Hegseth has announced plans to screen military members over 30 for “testosterone deficiency,” a move that has been met with skepticism by medical experts. They argue that such screenings are not only unnecessary but also potentially counterproductive.

The controversy centers on the conflation of physical appearance and masculinity, which is reinforced by Hegseth’s emphasis on ensuring soldiers have “the right testosterone levels to operate at your absolute best.” This notion is scientifically dubious and outmoded.

Medical organizations, including The Endocrine Society and the American College of Physicians, recommend against general screenings for low testosterone. They cite concerns about overdiagnosis and overtreatment due to fluctuations in hormone levels caused by age, lifestyle, and even time of day.

Doctors question the logic behind screening younger service members who may not be at risk for low testosterone. “Young men have very low risk of having low testosterone,” notes Dr. Marcus Goncalves, director of the Holman Division of Endocrinology, Diabetes, and Metabolism at NYU Langone Health. He points out that symptoms associated with low testosterone can also be caused by 20 other reasons.

The testing process itself is complex and expensive. Determining a person’s levels requires precise timing – ideally between 8 and 10 a.m., when testosterone is typically at its highest point. Fasting before the test is also recommended, and repeated tests are often necessary to confirm low levels, leading to months of medical appointments and testing.

The costs of this program will likely be astronomical, with estimates suggesting tens of millions of dollars per year in blood draws alone. Follow-up tests, treatment, and monitoring will only add to the financial burden.

There is no published analysis showing that screening men for low testosterone is a good use of money. The Endocrine Society has already concluded that it’s not worth doing. By pushing ahead with this program, the military is essentially ignoring scientific consensus in favor of a dubious prescription for military masculinity.

The risks associated with testosterone replacement therapy are significant. Long-term use can lead to increased risk of blood clots, kidney injuries, and impaired fertility. The widespread screenings needed could produce false positive results, leading to unnecessary medical testing and overtreatment.

Hegseth’s plan raises more questions than answers. What exactly is being measured here – masculinity or physical performance? Is this a genuine attempt to boost soldierly vigor or simply another example of the military’s willingness to conform to outdated notions of masculinity?

The debate over this policy continues, but one thing is clear: the science just doesn’t support it. It’s time for the military to rethink its approach and prioritize evidence-based decision-making over ideological posturing. The soldiers who will be affected by this program deserve better – and so does the nation they serve.

Reader Views

  • RJ
    Reporter J. Avery · staff reporter

    The proposed testosterone screening program for military personnel raises more questions than answers. While it's true that some service members may experience low testosterone due to age or medical conditions, targeting younger individuals under 30 seems misplaced. With a wide range of potential causes for symptoms associated with low testosterone, these screenings could lead to misdiagnosis and unnecessary treatment. Moreover, the complexity and expense of the testing process – not to mention the bureaucratic overhead – make this initiative seem more about perpetuating a dubious narrative about masculinity than genuinely improving military performance.

  • EK
    Editor K. Wells · editor

    This testosterone screening plan reeks of a misguided attempt to impose a narrow definition of masculinity on military personnel. What's missing from this narrative is how this policy will impact already underrepresented groups in the military, such as women and minorities who may not fit traditional notions of masculinity. Will they be disproportionately affected by overdiagnosis or coerced into unnecessary treatment? The Defense Secretary's emphasis on testosterone levels ignores the complexity of human experience and reduces individuals to a single biochemical marker.

  • AD
    Analyst D. Park · policy analyst

    This testosterone screening plan is a misguided attempt to codify traditional notions of masculinity in the military. While I agree with medical experts that overdiagnosis and overtreatment are significant concerns, there's another issue at play: the erosion of trust between healthcare providers and patients. Without clear guidelines on what constitutes "low" testosterone levels, service members may be subjected to lengthy testing processes, only to receive inconclusive results or unnecessary treatment. This approach undermines the already fragile doctor-patient relationship, leading to potential long-term psychological consequences for those involved.

Related articles

More from Bullty

View as Web Story →